Baidu
map

国家药监局给提地位 执业药师可参评职称

2018-08-23 杨瑞静 健康界

继国家卫健委给予药师审核处方权后,国家药监局又为执业药师提升地位。8月22日,国家药监局发布《执业药师职业资格制度规定(征求意见稿)》(下称《规定》),《规定》指出,通过全国统一考试,并取得《执业药师职业资格证书》的人员,且符合职称评审相应条件的,视为具备主管药师或主管中药师职称。执业药师实行注册制度、通过考试即为主管药师、执业药师要参加继续教育、“挂证”行为被严厉打击……随着执业药师专业技术价

继国家卫健委给予药师审核处方权后,国家药监局又为执业药师提升地位。

8月22日,国家药监局发布《执业药师职业资格制度规定(征求意见稿)》(下称《规定》),《规定》指出,通过全国统一考试,并取得《执业药师职业资格证书》的人员,且符合职称评审相应条件的,视为具备主管药师或主管中药师职称。

执业药师实行注册制度、通过考试即为主管药师、执业药师要参加继续教育、“挂证”行为被严厉打击……随着执业药师专业技术价值的体现,执业药师的地位也在提高。

执业药师是什么?

《规定》指出,执业药师是指经全国统一考试合格,取得《中华人民共和国执业药师职业资格证书》并经注册,在药品生产、经营、使用和其他需要提供药学服务的单位中执业的药学技术人员。

同时,《规定》要求执业药师应按国家有关规定参加继续教育,国家鼓励执业药师参加实训培养。

《规定》指出,延续注册者,还应当按规定修满继续教育学分。也就是说,想要一直做执业药师,就必须一直参加继续教育。

那么,如何能成为一名执业药师?先考试。

考试好考吗?准入条件提高了

随着执业药师专业技术价值的体现,其准入条件也被提高。

与以往不同的是,《规定》对执业药师资格考试准入学历门槛从中专提高到大专。

为了弥补执业药师人员缺口,《规定》放宽对药师考试的准入年限限制。《规定》中,对具有普通高等院校药学类、中药学类大学本科学历人员,由原来的在药学或中药学岗位工作满三年,修改为没有工作年限要求,对具有药学类、中药学类相关专业大学本科学历人员的工作年限要求,由原来的在药学或中药学岗位工作满三年降为满一年。

执业药师注册后才能上岗

通过考试,执业药师就可以上岗了?还得经过注册。

《规定》指出,执业药师实行注册制度。取得《执业药师职业资格证书》者,经执业注册后,方可从事相应的执业活动。未经执业注册者,不得以执业药师身份执业。执业药师只能在一个省、自治区、直辖市注册。

《规定》不再要求执业药师注册须经所在单位同意,简化了执业药师的注册手续。

同时,执业药师的违法违规行为、接受表彰奖励及处分、继续教育学分等重要信息,都将纳入全国执业药师注册管理信息系统。

前途无量 执业药师有职称了

职称与资格有别,其价值更高。如今,执业药师也将拥有职称体系。

《规定》指出,通过全国统一考试取得《执业药师职业资格证书》的人员,且符合职称评审相应条件的,视为具备主管药师或主管中药师职称。

同时,国家药监局在《修订说明》中提到,执业药师所在单位根据工作需要,可聘任其为主管药师或主管中药师专业技术职务。这将意味着,执业药师将获得更高的报酬及社会地位。

执业药师要做什么?这两点是必选项

无论做什么,执业药师都要遵守执业标准和业务规范,以对药品质量负责、保证公众用药安全有效为基本准则。

按照《规定》内容,执业药师主要职责有两条:

一是,执业药师在执业范围内负责对药品质量的监督和管理,参与制定、实施药品全面质量管理及对本单位违反规定的处理。

二是,执业药师负责处方的审核及调配,提供用药咨询与信息,指导合理用药,开展治疗药物监测及药品疗效评价等临床药学工作。

手段升级 挂证者三年不能执业

执业药师兼职挂靠已经蔚然成风,随着打击力度加大,挂证风险将越来越高。

《规定》指出,出租出借《执业药师注册证》的,由发证部门宣布证书无效,责令收回或者予以没收,三年内不予执业药师注册,涉及违规执业药师和违规企业,按照相关法律法规给予处罚。

《规定》不仅对执业药师行为加以约束,也加大了对相关单位的约束力度。

其中,执业药师成为药店的“标准配备”。《规定》指出,凡从事药品生产、经营、使用的单位,均应配备相应的执业药师。

同时,《规定》指出,经营处方药的药品零售企业,执业药师不在岗时,应当以醒目方式公示,并暂停销售处方药。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1646316, encodeId=530716463166b, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Thu May 23 05:48:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301607, encodeId=b139130160ef8, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411919, encodeId=e3dd141191969, content=<a href='/topic/show?id=f52f54e225f' target=_blank style='color:#2F92EE;'>#执业药师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54722, encryptionId=f52f54e225f, topicName=执业药师)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac32820101, createdName=3631174, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429170, encodeId=81c114291e0d1, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518330, encodeId=6c4915183305d, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340465, encodeId=461b340465e5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Fri Aug 24 06:56:04 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340450, encodeId=e9e3340450c1, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Aug 24 06:10:09 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2019-05-23 维他命
  2. [GetPortalCommentsPageByObjectIdResponse(id=1646316, encodeId=530716463166b, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Thu May 23 05:48:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301607, encodeId=b139130160ef8, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411919, encodeId=e3dd141191969, content=<a href='/topic/show?id=f52f54e225f' target=_blank style='color:#2F92EE;'>#执业药师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54722, encryptionId=f52f54e225f, topicName=执业药师)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac32820101, createdName=3631174, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429170, encodeId=81c114291e0d1, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518330, encodeId=6c4915183305d, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340465, encodeId=461b340465e5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Fri Aug 24 06:56:04 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340450, encodeId=e9e3340450c1, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Aug 24 06:10:09 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2018-08-25 xuyu
  3. [GetPortalCommentsPageByObjectIdResponse(id=1646316, encodeId=530716463166b, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Thu May 23 05:48:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301607, encodeId=b139130160ef8, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411919, encodeId=e3dd141191969, content=<a href='/topic/show?id=f52f54e225f' target=_blank style='color:#2F92EE;'>#执业药师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54722, encryptionId=f52f54e225f, topicName=执业药师)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac32820101, createdName=3631174, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429170, encodeId=81c114291e0d1, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518330, encodeId=6c4915183305d, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340465, encodeId=461b340465e5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Fri Aug 24 06:56:04 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340450, encodeId=e9e3340450c1, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Aug 24 06:10:09 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1646316, encodeId=530716463166b, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Thu May 23 05:48:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301607, encodeId=b139130160ef8, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411919, encodeId=e3dd141191969, content=<a href='/topic/show?id=f52f54e225f' target=_blank style='color:#2F92EE;'>#执业药师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54722, encryptionId=f52f54e225f, topicName=执业药师)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac32820101, createdName=3631174, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429170, encodeId=81c114291e0d1, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518330, encodeId=6c4915183305d, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340465, encodeId=461b340465e5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Fri Aug 24 06:56:04 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340450, encodeId=e9e3340450c1, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Aug 24 06:10:09 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1646316, encodeId=530716463166b, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Thu May 23 05:48:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301607, encodeId=b139130160ef8, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411919, encodeId=e3dd141191969, content=<a href='/topic/show?id=f52f54e225f' target=_blank style='color:#2F92EE;'>#执业药师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54722, encryptionId=f52f54e225f, topicName=执业药师)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac32820101, createdName=3631174, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429170, encodeId=81c114291e0d1, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518330, encodeId=6c4915183305d, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340465, encodeId=461b340465e5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Fri Aug 24 06:56:04 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340450, encodeId=e9e3340450c1, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Aug 24 06:10:09 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2018-08-25 xxxx1053
  6. [GetPortalCommentsPageByObjectIdResponse(id=1646316, encodeId=530716463166b, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Thu May 23 05:48:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301607, encodeId=b139130160ef8, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411919, encodeId=e3dd141191969, content=<a href='/topic/show?id=f52f54e225f' target=_blank style='color:#2F92EE;'>#执业药师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54722, encryptionId=f52f54e225f, topicName=执业药师)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac32820101, createdName=3631174, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429170, encodeId=81c114291e0d1, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518330, encodeId=6c4915183305d, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340465, encodeId=461b340465e5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Fri Aug 24 06:56:04 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340450, encodeId=e9e3340450c1, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Aug 24 06:10:09 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2018-08-24 lietome24

    感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1646316, encodeId=530716463166b, content=<a href='/topic/show?id=080d5469e79' target=_blank style='color:#2F92EE;'>#执业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54697, encryptionId=080d5469e79, topicName=执业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a523305089, createdName=维他命, createdTime=Thu May 23 05:48:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301607, encodeId=b139130160ef8, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411919, encodeId=e3dd141191969, content=<a href='/topic/show?id=f52f54e225f' target=_blank style='color:#2F92EE;'>#执业药师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54722, encryptionId=f52f54e225f, topicName=执业药师)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac32820101, createdName=3631174, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429170, encodeId=81c114291e0d1, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518330, encodeId=6c4915183305d, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Sat Aug 25 13:48:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340465, encodeId=461b340465e5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Fri Aug 24 06:56:04 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340450, encodeId=e9e3340450c1, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Aug 24 06:10:09 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2018-08-24 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

相关资讯

国家药监局深夜开会 说了六点

8月16日晚,国家药品监督管理局紧急召开干部大会,传达中共中央政治局常务委员会会议关于吉林长春长生公司问题疫苗案件调查处理的决定。市场监管总局局长张茅,国家药监局党组书记、副局长李利,局长焦红出席会议并讲话,局机关司局和直属单位负责人参加会议。会议要求,全局机关各司局、各直属单位党组织和全体干部职工要深刻学习领会和坚决贯彻落实习近平总书记重要指示精神,提高政治站位,牢固树立“四个意识”,按照“四

药监局、卫健委三定方案出炉!

今日,国家市场监督管理总局、国家药品监督管理局、国家卫生健康委员会同时发布“三定方案”。

药监局余震不断:大批司长、副司长被免职!

8月18日,国家市场监督管理总局官网发布消息,针对疫苗案,继续追查原食药总局、国家药监局内部失责人员,从严处理,对一批司长、副司长级官员予以免职。

国家药监局:这些药加快上市

在仿制药方面,重点提到激励药品仿制,加快推进仿制药品质量和疗效一致性评价工作,逐步提高已上市药品质量,并制定发布在临床上与原研药品相互替代的药品目录,即中国上市药品目录集。要求仿制药与原研药一致,实现临床可替代,从而提高仿制药质量,降低医疗费用。

卫健委、医保局、药监局有哪些新动作?一文说透

今年3月21日,中共中央印发《深化党和国家机构改革方案》,一批新部门应运而生。在本轮机构改革中,有三个新组建的部门和“医药”有关,分别是国家卫健委、国家医疗保障局、国家药品监督管理局。在3月末到5月末,这三个部门先后挂牌成立。因事关“民生”,机构改革后,在一些备受公众关注的事件和涉及大众利益的改革中,时常可以看到这三个部门的“身影”、听到它们的“发声”。那么,从决定组建到现在的130多天里,

国家药监局:将对所有疫苗企业进行飞行检查

国家药监局表示,将组织对所有疫苗生产企业进行飞行检查,对违反法律法规规定的行为要严肃查处。7月22日,针对“狂犬病疫苗生产记录造假”事件,国家药监局在官网通报最新调查进展。通报说,现已查明,企业编造生产记录和产品检验记录,随意变更工艺参数和设备。目前,国家药监局已责令长春长生停止生产,并收回药品生产质量管理规范(GMP)证书,同时会同吉林省局已对企业立案调查,涉嫌犯罪的移送公安机关追究刑事责

Baidu
map
Baidu
map
Baidu
map